II-Bromo-1. [4 (Methyllsulfonyl) Phenyl] -1-Ethanone
![II-Bromo-1. [4 (Methyllsulfonyl) Phenyl] -1-Ethanone Featured Image](https://cdn.globalso.com/jingyepharma/50413-24-6.jpg)
Synonyma:II-Bromo-IV '- (Methyllsulphonyl) Acetophenone, II-Bromo-1. [4 (10thllsulphonyl) Phenyl] -1-Ethanone; IV-Methyllsulfonyl, A-Bromoacetopyenone; IV-Methyllsulfonyl, A-Bromusacetophenóneogenone; IV, Methyllsulfonylalpha, Bromoacetophenone; 4 (Methyllsl) PhenacyLbromide; Alpha, Bromo-IV-methylsulfonaceTophenhenone; IV-methylsphonyl, alpha, bromoacetophenone; II-Bromo-IV '- (Methyllsulfonyl) Acetophenone.
CAS non.:50413-24-6
Molecular formula:C9H9Bro3S
Molecular pondus:277.14
Usus:CarbonyL Composita
Application:Pharmaceuticals, Intermedia, Apis, Custom Synthesis, alchimicis
Structura
Superioritatis:Optimus vendit, altum qualitas, competitive pretium, ieiunium partus, velox responsum
Related Categories:Medicamento substantia; Ketone; Pharmaceutical intermedia; Organicum medium; Chemical medium; Acyll halides; Phenyls & Phenyl, Het; Acyll halides; Phenyls & Phenyl, Het
| Point liquescens | CXXVI ° C |
| PRAETERITUS | 428,4 ± 41.0 ° C (praedicta) |
| Densitas | 1.575 ± 0.06 G / CM3 (praedicta) |
| Repono condicionem | Custodi in tenebris est, inerti atmosphaera, locus temperatus |
| Disce Category Code | 34-36 |
| Salus statements | 26-36 / XXXVII / 39-45 |
| Periculo bona translationem non | MMMCCLXI |
| Aleam note | CORREROSUS |
| Aleam gradu | Irritamentum |
| Genus packaging | II |
| Special Specifications secundum Customer Requirements | |
| Species | Lux flavo ad album crystalline pulveris |
| Puritas (HPLC) | 98.0% min |
Præpicua enim tutum pertractatio:
Pertractatio in bene ventilari loco. Gerunt idoneam tutela vestimentum. Vitare contactus cum cutis et oculos. Vitare formationem pulveris et aerosols. Usus non-sparking tools. Ne ignis per electrostatic missionem vapor.
Condiciones ad tutum repono, inter aliqua incompatibilities:
Store in vas arcte clausa in sicco, frigus et bene uentilandam locum. Store seorsum ex foodstuff continentia aut repugnat materials.
Jingye habet LXXXVI sets of reactors in summa, de quo in voluptua electorum reactor est LXIX, a L ad 3000L. Numerus immaculatam reactors est XVIII, a L in 3000L. QC instructa centum omnes analyticae instrumentis. Potest occurrit in commercial productio et comprehensive analysis de productum. Hoc productum est superior macula productum et liberari potest secundum mos necessitates.
Jiangsu Jingye Pharmaceutical Co., Ltd. est olim nominatur Jintan Depei eget Co., Ltd, qui in MCMXCIV, et vicissim ad professional pharmaceutical manufacturer in MMXVI. Postquam DECIFICIUS et D, productio et export Duo subsidiaries sita in Shanghai et Lianyungang.